Skip to main content
Full access
Letters
Published Online: 1 January 2014

Nonketotic Hyperglycemia Presenting as Choreoathetosis in a Female Schizophrenia Patient

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Hemiballism or hemichorea caused by nonketotic hyperglycemia is an initial manifestation of diabetes. Here, we share our experience of the detection and treatment of nonketotic hyperglycemia-induced involuntary movement in a schizophrenia patient.

Case Report

Mrs. A is a 79-year-old woman with a diagnosis of schizophrenia from the time she was 28 years old. She was treated with thioridazine 100 mg per day from the time she was 47 years old. The medication was changed to risperidone 2 mg per day after she became 75 years old. She had no history of any systemic diseases, substance abuse, or head injury.
She presented to our hospital in March 2013 with a 2-week history of involuntary movements such as sudden-onset, continuous, and nonrhythmic movements in the form of flailing and twisting involving her right limbs. Her psychotic symptoms remained stationary. Neurological examination revealed normal muscle power without cerebellar signs or cranial nerve palsy. The most striking finding was choreoathetosis over the right limbs with prominence in the upper limbs. Electroencephalography revealed generalized, intermittent theta slowing. Laboratory examination showed HbA1C 14.4%, triglyceride 252 mg/dl, total cholesterol 200 mg/dl, and fasting blood glucose 309 mg/dl; hemogram, liver enzyme, renal function, and thyroid profile were within normal limits. MRI of the brain showed T1 hyperintensity at left basal ganglion (Figure 1). After treatment with metformin 500 mg per day, the involuntary movement diminished gradually and disappeared 2 weeks later. The fasting sugar and HbA1C returned within normal limits 3 months later. Up to this point, the involuntary movement never recurred.
Figure 1. MRI of the Brain Showing T1 Hyperintensity at Left Basal Ganglion

Discussion

Our patient presented with acute onset of involuntary choreoathetosis movement over the right limbs. Vascular lesion at subthalamic nucleus was the most possible cause.1 However, MRI revealed TI hyperintensity at left basal ganglion instead of subthalamic lesion.2 Meanwhile, hyperglycemia was noted, and the involuntary movement remitted after diabetes control.
In addition to vascular lesion, metabolic derangements, hyperglycemia, hyperthyroidism, tumor, and infection are associated with hemiballism or hemichorea/choreoathetosis.1 Sometimes, hemiballism or hemichorea caused by nonketotic hyperglycemia is an initial manifestation of diabetes, especially for elderly Asian females.3,4The typical brain MRI findings of these nonketotic hyperglycemia- induced involuntary movement are increased signal intensity on T1-weighted images over striatum and, similarly, left basal ganglion T1 hyperintensity were noted in our patient. After correcting the metabolic derangement, her involuntary movement ceased. In previous studies, the abnormalities of neuroimaging were shown to be reversible.3 We suggest that our patient’s acute hemichoreoathetosis was caused by hyperglycemia, despite lack of following imaging study.
Because our patient was a case of chronic schizophrenia, tardive dyskinesia induced by long-term neuroleptics use should be considered, and the manifestations that differed from our patient were involuntary movements mainly over tongue, lips, jaw, and extremities with insidious onset and slow progress. To the best of our knowledge, this is the first report of a schizophrenic patient with hemiballism or hemichorea caused by nonketotic hyperglycemia; 42.7% of patients treated with second-generation antipsychotics had metabolic dysregulation in previous literature.5 Our patient presented with a movement disorder caused by nonketotic hyperglycemia without a previous history of diabetes. Correct metabolic derangement achieved complete remission of movement disorder. Metabolic profiles should be assessed periodically in schizophrenia patients, and patients with new-onset involuntary movement should be evaluated for the probable metabolic comorbidities.

References

1.
Dewey RB Jr, Jankovic J: Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients. Arch Neurol 1989; 46:862–867
2.
Lin JJ, Lin GY, Shih C, et al: Presentation of striatal hyperintensity on T1-weighted MRI in patients with hemiballism-hemichorea caused by non-ketotic hyperglycemia: report of seven new cases and a review of literature. J Neurol 2001; 248:750–755
3.
Oh SH, Lee KY, Im JH, et al: Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: a meta-analysis of 53 cases including four present cases. J Neurol Sci 2002; 200:57–62
4.
Narayanan S: Hyperglycemia-induced hemiballismus hemichorea: a case report and brief review of the literature. J Emerg Med 2012; 43:442–444
5.
McEvoy JP, Meyer JM, Goff DC, et al: Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005; 80:19–32

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E25 - E26
PubMed: 26037876

History

Published online: 1 January 2014
Published in print: Fall 2014

Authors

Affiliations

Meng-Chao Tsai, M.D.
Dept. of General Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei City, Taiwan
Jeng-Ming Yu, M.D.
Dept. of General Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei City, Taiwan
Shyi-Jye Duh, M.D.
Dept. of Radiology, Taipei City Hospital Ren-Ai Branch, Taipei City, Taiwan
Wuu-Jeng Chen, M.D.
Dept. of Internal Medicine, Taipei City Psychiatric Center, Taipei City Hospital, Taipei City, Taiwan l
Hsing-Cheng Liu, M.D., Ph.D.
Dept. of General Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei City, Taiwan
Dept. of Psychiatry, School of Medicine, Taipei Medical University, Taipei City, Taiwan

Notes

Send correspondence to Dr. Liu; e-mail: [email protected]

Funding Information

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share